David P. Kelsen

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino, Han Sang Kim, Linda Bojmar et al. · Cell · 2020 · 1.2K citations · Full text

Tumor Biology, Extracellular Vesicle, Medicine +5

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

Ki Y. Chung, Jinru Shia, Nancy E. Kemeny et al. · Journal of Clinical Oncology · 2005 · 1.1K citations · Full text

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 440 citations

Oncology, Phase Ii Trial, Pancreatic Cancer +5

Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Manish A. Shah, Ramesh K. Ramanathan, David H. Ilson et al. · Journal of Clinical Oncology · 2006 · 409 citations

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face

Farid Fata, Eileen M. O’Reilly, David H. Ilson et al. · Cancer · 1999 · 387 citations · Full text